Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page
- Check5 days agoChange DetectedThe page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the recruitment status to No longer looking for participants, indicating no current enrollment. A header formatting change and a revision label update are also present.SummaryDifference0.5%

- Check12 days agoChange Detected- The page revision was updated from v3.5.4 to v3.5.5, signaling a minor page-level update. No study content, eligibility criteria, or results information appear to have changed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange Detected- The page revision label was updated to v3.5.4, replacing the previous v3.5.3 and signaling a minor update to the page without changing its study details.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, representing a new version of the study record. This change signals a minor update to the page's versioning without altering the substantive study information.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed, updating the page's version metadata without changes to the core study details.SummaryDifference0.1%

- Check91 days agoChange DetectedVersion updated from v3.4.3 to v3.5.0 on the page, indicating a platform-level update without changes to study data or content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.